miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer

miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer

Our previous study demonstrated that miR-124 was downregulated in colorectal cancer (CRC) compared with normal mucosa, and the downregulated expression of miR-124 was an independent prognostic factor in CRC patients. However, the function of miR-124 in CRC patients treated with chemotherapy is curre...

Full description

Bibliographic Details
Main Authors:	Xu-Qin Xie, Mo-Jin Wang, Yuan Li, Lin-Ping Lei, Ning Wang, Zhao-Ying Lv, Ke-Ling Chen, Bin Zhou, Jie Ping, Zong-Guang Zhou, Xiao-Feng Sun
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	Molecular Therapy: Oncolytics
Subjects:	colorectal cancer miR-124 CAPN2 oxaliplatin chemotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S237277052030053X

Similar Items

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
by: Yuanyuan Yu, et al.
Published: (2021-05-01)

KCNQ1OT1 promotes ovarian cancer progression via modulating MIR‐142‐5p/CAPN10 axis
by: Hongli Liu, et al.
Published: (2020-02-01)

The Role of MiR-124 in Bladder Cancer – A Review of the Literature
by: Petcu Costin, et al.
Published: (2021-01-01)

MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer
by: Xiaoyuan Lu, et al.
Published: (2021-07-01)

miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity
by: Yongqiang Hua, et al.
Published: (2018-12-01)

Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
by: Guoxiu Wang, et al.
Published: (2018-05-01)

Association of CAPN10 haplotype combinations with type 2 diabetes mellitus and metabolic syndrome among Egyptians: pilot study—genotyping of three CAPN10 variants
by: Shaymaa W. El-Far, et al.
Published: (2022-02-01)

MicroRNA-124 (MiR-124) Inhibits Cell Proliferation, Metastasis and Invasion in Colorectal Cancer by Downregulating Rho-Associated Protein Kinase 1(ROCK1)
by: Liqing Zhou, et al.
Published: (2016-05-01)

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk
by: Mototsugu Shimokawa, et al.
Published: (2021-10-01)

Knockdown of Mir-135b Sensitizes Colorectal Cancer Cells to Oxaliplatin-Induced Apoptosis Through Increase of FOXO1
by: Yan Qin, et al.
Published: (2018-08-01)

Relapsed urachal carcinoma responding to first‐line chemotherapy with capecitabine‐oxaliplatin plus bevacizumab
by: Akihiko Hatano, et al.
Published: (2023-11-01)

Characterization of the Goose CAPN3 Gene and its Expression Pattern in Muscle Tissues of Sichuan White Geese at Different Growth Stages
by: Hengyong Xu, et al.
Published: (2018-07-01)

Biallelic variants in the calpain regulatory subunit CAPNS1 cause pulmonary arterial hypertension
by: Alex V. Postma, et al.
Published: (2023-01-01)

Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports
by: Luiza Damian Ribeiro Barbosa, et al.
Published: (2016-02-01)

COMPARING THE SUBGINGIGVAL MICROBIOME COMPOSITION DURING OXALIPLATIN CHEMOTHERAPY IN A PATIENT WITH COLON CANCER. CASE REPORT
by: Diana-Cristala Kappenberg-Niţescu, et al.
Published: (2019-01-01)

NOVEL SNP OF CALPAIN-1 (CAPN1) GENE AND ITS ASSOCIATION WITH CARCASS AND MEAT CHARACTERISTICS TRAITS IN BALI CATTLE
by: N. Pratiwi, et al.
Published: (2016-08-01)

MiR-454-3p Promotes Oxaliplatin Resistance by Targeting PTEN in Colorectal Cancer
by: Xiao-Lan Qian, et al.
Published: (2021-05-01)

Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study
by: Imai H, et al.
Published: (2022-03-01)

Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status
by: M. Yu. Fedyanin, et al.
Published: (2018-05-01)

Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials
by: Gerardo Rosati, et al.
Published: (2019-04-01)

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event
by: Henriette Quack, et al.
Published: (2013-12-01)

Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
by: Philip Falk, et al.
Published: (2022-01-01)

CAPN8 involves with exhausted, inflamed, and desert immune microenvironment to influence the metastasis of thyroid cancer
by: Xiang Zhong, et al.
Published: (2022-10-01)

Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy
by: Cham A, et al.
Published: (2016-06-01)

Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice
by: A.F. Pereira, et al.
Published: (2020-09-01)

Oxaliplatin-induced Sudden Hearing Loss in a Patient with Pancreatic Cancer
by: Sung Bum Kim, et al.
Published: (2020-11-01)

Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
by: Renata Ferrarotto, et al.
Published: (2013-09-01)

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
by: Astrid E. Slagter, et al.
Published: (2022-06-01)

Clinical Analysis of Oxaliplatin-related Thrombocytopenia in Patients with Digestive System Malignancy
by: DAI Yuhong, et al.
Published: (2021-05-01)

miR-34a-5p enhances the sensitivity of cervical cancer cells to oxaliplatin chemotherapy via targeting MDM4
by: Pei He, et al.
Published: (2022-02-01)

Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review
by: Francesca Barbin, et al.
Published: (2022-12-01)

Optimized miR-124 reporters uncover differences in miR-124 expression among neuronal populations in vitro
by: Catherine Lepolard, et al.
Published: (2023-10-01)

Capn4 regulates Snail to promote the epithelial–mesenchymal transition of nasopharyngeal carcinoma by mediating the transcriptional activity of claudin‐11
by: Feng Yang, et al.
Published: (2023-02-01)

Mechanism of LINC00601 in regulating sensitivity of hepatocellular carcinoma cells to oxaliplatin chemotherapy
by: HU Keshu, LIU Wenfeng, ZHANG Feng, QUAN Bing, YIN Xin
Published: (2023-01-01)

MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders
by: Dong Han, et al.
Published: (2020-01-01)

Overexpressed GATA3 enhances the sensitivity of colorectal cancer cells to oxaliplatin through regulating MiR-29b
by: Wei Wang, et al.
Published: (2020-07-01)

LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer
by: Xiangfeng Meng, et al.
Published: (2020-12-01)

Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome
by: Hong Wang, et al.
Published: (2017-08-01)

Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer
by: Mehrdad Hashemi, et al.
Published: (2024-02-01)

Results of using tegafur in combination with irinotecan and oxaliplatin in patients with advanced colorectal cancer
by: N. V. Dobrova, et al.
Published: (2018-11-01)